Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Hyperphenylalaninemia in Cerebral Malaria

This study has been completed.
Sponsor:
Collaborators:
Hubert Kairuki Memorial University
Duke University
Information provided by (Responsible Party):
University of Utah
ClinicalTrials.gov Identifier:
NCT00338520
First received: June 15, 2006
Last updated: October 19, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)